Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours con

Stroke

Volumn 36, Issue 5, 2005, Pages 1099-1100

  Zivin, Justin A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diffusion magnetic resonance imaging; Magnetic resonance imaging

Indexed keywords

ALTEPLASE; CONTRAST MEDIUM;

CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; HISTOPATHOLOGY; HUMAN; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; SHORT SURVEY; STROKE;

EID: 18244381509     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000162389.44928.de     Document Type: Short Survey

References (3)

1. Chapman D, Lyden P, Lapchak PA, Nunez S, Thibodeaux H, and Zivin J. Comparison of TNK with wild-type-t-PA in a rabbit thromboembolic stroke model: thrombolytic efficacy and incidence of cerebral hemorrhage. Stroke. 2001;32:748-752.
2. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A, Olkers P, Hirsch JG, Heiland S, Wilde P, Jansen O, Rother J, Hacke W, Sartor K. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. Stroke. 2004;35:502-506.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.